⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 33 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 22 minutes ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 33 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 22 minutes ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT February 23, 2026

Nustendi 180 mg/10 mg Filmtabletten 180 mg/10 mg (Filmtablette)

📷 Wikipedia: Ezetimibe · Source
Nustendi 180 mg/10 mg Filmtabletten 180 mg/10 mg (Filmtablette)
📷 Wikipedia: Ezetimibe · Source
Nustendi 180 mg/10 mg film-coated tablets are subject to a parallel export ban. Supply is delayed due to manufacturing issues. Affected packs: 28-tablet blister boxes are unavailable since 23 February 2026 and expected to return on 29 June 2026; 14-tablet blister boxes remain available.
✅
Resolved by agency
The issuing agency has confirmed this medicine alert is over — the underlying issue was addressed. Originally reported 203 days ago.
📈 Timeline
70 days in total
May 27, 2026 August 5, 2026

What is this? Nustendi is a tablet used to lower cholesterol. It contains two medicines: bempedoic acid and ezetimibe.

What's happening? The 28-tablet pack is out of stock. The 14-tablet pack is still available. A new supply is expected in June.

Does this affect me? If you take the 28-tablet pack, you may need to switch to the 14-tablet pack or another medicine.

What should I do? Talk to your pharmacist or doctor before changing your medicine.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
BEMPEDOSÄURE EZETIMIB
Agency-published detail

🚫 Parallel export ban active · ATC: C10B · Reason: Verzögerung bei der Herstellung · Marketing authorisation holder: Daiichi Sankyo Europe GmbH, Zielstattstraße 48, 81379 München, Federal Republic of Germany · Affected packs: 28 Stück Blisterpackung, Schachtel [Nicht verfügbar, since 2026-02-23, resupply 2026-08-07] · 14 Stück Blisterpackung, Schachtel [verfügbar, since 2026-06-16, resupply 2026-07-28]

First published
February 23, 2026
Last refreshed by us
1 month ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

High AT 6 days ago

Ezetimib/Simvastatin Actavis 10 mg/20 mg Tabletten 10/20 mg/mg (Tablette)

🚫 Parallel export ban active · ATC: C10BA02 · Reason: Verzögerung bei der Herstellung · Marketing authorisation holder: Actavis Group PTC ehf., Dalshraun 1, 220 Hafnarfjördur, Republic of Iceland · A...
High AT 6 days ago

Nilemdo 180 mg Filmtabletten 180 mg (Filmtablette)

Nilemdo 180 mg film-coated tablets are subject to a parallel export ban. Supply is delayed due to manufacturing issues. Affected packs include the 28-tablet blister pack, which is unavailable, and the...
High AT 2 weeks ago

Atozet 10 mg/10 mg Filmtabletten 10/10 mg (Filmtablette)

Atozet 10 mg/10 mg film-coated tablets are unavailable due to manufacturing capacity issues. The affected packs are the 30-tablet blister box.
High AT 2 weeks ago

Ezetimib/Atorvastatin HCS 10 mg/40 mg Filmtabletten 10/40 mg (Filmtablette)

Ezetimib/Atorvastatin HCS 10 mg/40 mg film-coated tablets are unavailable due to a manufacturing delay.
High AT 3 weeks ago

Rosuvastatin/Ezetimib HCS 5 mg/10 mg Filmtabletten 5/10 mg (Filmtablette)

Rosuvastatin/Ezetimib HCS 5 mg/10 mg film-coated tablets are subject to a parallel export ban. Supply is delayed due to manufacturing issues. Affected packs are the 30-tablet box and blister pack, cur...
Medium AT resolved 1 month ago

Ezetimib/Atorvastatin HCS 10 mg/10 mg Filmtabletten 10/10 mg (Filmtablette)

Ezetimib/Atorvastatin HCS 10 mg/10 mg film-coated tablets are delayed in production. Affected packs include boxes of 30 tablets in blister packs.
High AT 2 months ago

Ezetimib HCS 10 mg Tabletten 10 mg (Tablette)

Ezetimib HCS 10 mg tablets (10 mg per tablet) are delayed in production. The affected packs are boxes of 30 tablets in blister packs. These are currently unavailable since 7 July 2026, with resupply e...
Low AT resolved 2 months ago

Rosuvastatin/Ezetimib ratiopharm 20 mg/10 mg Tabletten 20 mg/10 mg (Tablette)

Supply of rosuvastatin/ezetimibe 20 mg/10 mg tablets has been delayed.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Nustendi 180 mg/10 mg Filmtabletten 180 mg/10 mg (Filmtablette). Nustendi 180 mg/10 mg film-coated tablets are subject to a parallel export ban. Supply is delayed due to manufacturing issues. Affected packs: 28-tablet blister boxes are unavailable since 23 February 2026 and expected to return on 29 June 2026; 14-tablet blister boxes remain ava...
▸ When was this alert issued?
This alert was issued on February 23, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.